   
       
Head and Neck Cancer Studies
E1305 Principal Investigator: Larry Schlabach, MD
Co-Investigator: John McCravey, MD and Matt Graham, MD
Title: A Phase III Randomised Trial of chemotherapy With or WithoutBevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer. (IRB#: 08-106)
NCT #: NCT00588770 Phase: Phase III
Purpose:This randomized phase III trial is studying chemotherapy to see how well it works with or without bevacizumab in treating patients with recurrent or metastatic head and neck cancer.
Drugs possibly given:
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Fluorouracil
Please view complete information about this trial at: http://www.clinicaltrial.gov/ct2/show/NCT00588770?term=E1305&rank=1
|
